Stille AB (STO:STIL)
Sweden · Delayed Price · Currency is SEK 185.50
-5.00 (-2.62%)
Mar 2, 2026, 5:21 PM CET
Stille AB Revenue
In the year 2025, Stille AB had annual revenue of 567.63M SEK, down -0.41%. Stille AB had revenue of 174.88M in the quarter ending December 31, 2025, with 9.44% growth.
Revenue
567.63M
Revenue Growth
-0.41%
P/S Ratio
3.02
Revenue / Employee
2.59M
Employees
219
Market Cap
1.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 567.63M | -2.32M | -0.41% |
| Dec 31, 2024 | 569.95M | 275.06M | 93.27% |
| Dec 31, 2023 | 294.89M | 48.54M | 19.70% |
| Dec 31, 2022 | 246.35M | 59.26M | 31.68% |
| Dec 31, 2021 | 187.09M | 44.46M | 31.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Medicover AB | 25.74B |
| Sectra AB | 3.47B |
| Surgical Science Sweden AB | 992.34M |
| EQL Pharma AB | 425.75M |
| Carasent AB | 343.82M |
| Devyser Diagnostics AB | 250.50M |
Stille AB News
- 19 days ago - Stille AB (OSTO:STIL) Q4 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
- 4 months ago - Stille AB (OSTO:STIL) Q3 2025 Earnings Report Preview: What To Expect - GuruFocus
- 1 year ago - Stille AB (OSTO:STIL) Q4 2024 Earnings Report Preview: What to Look For - GuruFocus